Medivation, Inc. (MDVN) Tops Q2 EPS by 36c; Issues Confident FY14 Sales Outlook

Medivation, Inc. (NASDAQ: MDVN) reported Q2 EPS of $0.60, $0.36 better than the analyst estimate of $0.24. Revenue for the quarter came in at $148.1 million versus the consensus estimate of $126.46 million.

Medivation, Inc. sees FY2014 revenue of $600-640 million, versus the consensus of $651.74 million.

For earnings history and earnings-related data on Medivation, Inc. (MDVN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22